Literature DB >> 6379452

Differences in allopurinol and 4-aminopyrazolo(3,4-d) pyrimidine metabolism in drug-sensitive and insensitive strains of Trypanosoma cruzi.

J L Avila, A Avila, H Monzón.   

Abstract

Most freshly isolated Trypanosoma cruzi blood trypomastigotes were insensitive to allopurinol (HPP) and 4-aminopyrazolo(3,4-d)pyrimidine (APP). Strains EP and Ya were, however, strongly inhibited by both drugs while strains DS and A-35 were HPP-insensitive but APP-sensitive. In contrast, epimastigotes resulting from one in vitro passage of all eleven T. cruzi strains were highly sensitive to both drugs. While hypoxanthine/guanine and adenine phosphoribosyltransferase and succino-AMP synthetase activities were similar in trypomastigotes of sensitive and insensitive T. cruzi strains, the uptake and metabolism of [14C]HPP and [14C]APP was significantly slower in T. cruzi trypomastigotes of insensitive strains than in sensitive strains. The results suggest the importance of drug uptake rates in determining the pyrazolopyrimidine sensitivity of different T. cruzi strains.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6379452     DOI: 10.1016/0166-6851(84)90054-9

Source DB:  PubMed          Journal:  Mol Biochem Parasitol        ISSN: 0166-6851            Impact factor:   1.759


  3 in total

1.  Biological activity of analogs of guanine and guanosine against American Trypanosoma and Leishmania spp.

Authors:  J L Avila; T Rojas; A Avila; M A Polegre; R K Robins
Journal:  Antimicrob Agents Chemother       Date:  1987-03       Impact factor: 5.191

2.  Molecular biology studies of tubercidin resistance in Trypanosoma cruzi.

Authors:  T Nozaki; J A Dvorak
Journal:  Parasitol Res       Date:  1993       Impact factor: 2.289

3.  Therapeutic action of MK-436 (2,5-nitroimidazole) on Trypanosoma cruzi infections in mice: a parasitological, serological, histopathological, and ultrastructural study.

Authors:  S G Andrade; R C Silva; C M Santiago; L A Freitas
Journal:  Bull World Health Organ       Date:  1987       Impact factor: 9.408

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.